Another study demonstrated that MRPL33 expression is elevated in AML cell lines and correlates with receptor tyrosine kinase expression, such as TrkA or KIT, suggesting MRPL33 as a potential prognostic biomarker for AML (108). This evidence concerns the gene MRPL33 and acute myeloid leukemia.